Neurostimulation Devices Market - Industry Analysis and Forecast

Neurostimulation Devices Market - Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2030

12.3%

CAGR (2024-2030)

6.42 USD Bn.

Market Size

323

Report Pages

142

Market Tables

Overview

Neurostimulation Devices Market size was valued at USD 6.42 Billion in 2023 and the total Market revenue is expected to grow at a CAGR of 12.3% from 2024 to 2030, reaching nearly USD 14.46 Billion by 2030.

The research gives a comprehensive perspective of the market by combining qualitative and quantitative data. It examines the global Neurostimulation Devices Market and provides forecasts for the key segments. It also includes market size and forecast estimates for five key regions: North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America, for the years 2023 to 2030. The Neurostimulation Devices Market is further split into countries and markets within each location.To know about the Research Methodology :- Request Free Sample Report

Neurostimulation Devices Market Dynamics

Neurostimulation devices are expected to bring treatment to an unprecedented number of individuals suffering from significant neurologic and mental problems as technology advances. The market is expected to increase due to the availability of implanted neurostimulation devices that target particular cranial, spinal, and peripheral nerve regions to control neuronal activity and provide therapeutic benefits for a range of neurological illnesses.

Growing geriatric population, rising prevalence of chronic neurological disorders, increasing preference for minimally invasive surgical procedures due to advantages such as faster patient recovery, shorter hospital stay, less pain, and lower treatment costs are driving the global neurostimulation devices market revenue growth.

Restraints:

However, unfavourable factors such as negative side effects and hazards associated with neurostimulation devices, such as allergic responses and skin prickling, rising device costs, and the expanding availability of alternative treatment techniques are likely to hamper market revenue growth.

Trends:

Manufacturers are spending on R&D to produce new goods with advanced technology, such as Medtronic Inc.'s MRI safety-incorporated devices and Neurowave Medical Technologies' minimally invasive transdermal neuromodulation technology. Due to increased healthcare expenditures and high economic expansion in emerging countries such as India and China, Asia Pacific is expected to be the fastest-growing regional market from 2022 to 2029. The region's market growth is also aided by the availability of unmet medical requirements and unexplored markets. Changing lifestyles and eating habits, which result in a variety of lifestyle-related ailments, will also contribute to regional market growth. The rising number of RTAs and the resulting nerve damage, which necessitate postoperative neurostimulation, are also expected to raise product demand.

Neurostimulation Devices Market Segment Analysis

By Product, The spinal cord stimulator sector dominates the market in 2023, accounting for more than XX% of total revenue, thanks to a wide variety of product applications and significant market penetration of commercially available items. As a result of technical advancements, this field is expected to expand. Spinal cord stimulators create little nerve impulses without generating any physical changes to the target site, which is used to treat non-malignant chronic neuropathic pain.

By Application, in 2023, the pain management segment dominated the market, accounting for more than XX% of total revenue. The increasing prevalence of chronic pain problems, as well as expanding product usage for pain management due to its high therapeutic value, are driving this segment's growth. Over the forecast period, the segment is predicted to have the highest CAGR. Chronic pain, disc surgery pain, and leg pain are just a few of the disorders covered in this section.

Regional Insight

North America had the greatest revenue share of more than XX% in 2023, and this dominance is expected to continue over the forecast period. However, the region's growth may be hampered by rigorous government rules and an increase in the average number of days required in the FDA clearance procedure. In terms of revenue share, Europe came in second to North America. Eastern European nations' rapid economic development is likely to boost this trend even further. Additionally, because obtaining a CE clearance is easier than receiving an FDA approval, this region has a larger industrial penetration.

From 2022 to 2029, Asia Pacific, on the other hand, is expected to be the fastest-growing regional market. Due to the availability of unmet medical demands and unexplored growth opportunities, numerous global manufacturers are transferring their manufacturing bases to this region. Secondly, the market expansion in the APAC region is expected to be aided by rapid economic development in emerging countries such as India and China, as well as growing healthcare expenditures.

Report Objectives:

Landscape analysis of the Neurostimulation Devices Market
competitive benchmarking
Past and current status of the industry with the forecasted market size and trends
Evaluation of potential key players that include market leaders, followers, and new entrants
Technology trends
The potential impact of micro-economic factors on the market
External and Internal factors affecting the market have been analyzed

The report also helps in understanding the Neurostimulation Devices Market dynamics, and structure by analyzing the market segments to project the Neurostimulation Devices Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Neurostimulation Devices Market make the report investor’s guide.

Neurostimulation Devices Industry Ecosystem

Neurostimulation Devices Market Scope: Inquire before buying

Global Neurostimulation Devices Market
Report Coverage	Details
Base Year:	2023	Forecast Period:	2024-2030
Historical Data:	2018 to 2023	Market Size in 2023:	USD 6.42 Bn
Forecast Period 2024 to 2030 CAGR:	12.3%	Market Size in 2030:	USD 14.46 Bn
Segments Covered:	by Product	Spinal Cord Stimulator Deep Brain Stimulator Sacral Nerve Stimulator Vagus Nerve Stimulator Gastric Electric Stimulator
	by Application	Pain Management Epilepsy Essential Tremor Urinary and Fecal Incontinence Depression Dystonia Others

Neurostimulation Devices Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players are:

1. Medtronic
2. Cyberonics
3. Boston Scientific Corporation
4. St. Jude Medical
5. Nevro Corporation
6. Neuronetics Inc
7. NeuroPace Inc
8. NeuroSigma Inc
9. Cochlear Ltd
10. NDI Medical
11. Synapse Biomedical Inc
12. MED-EL
13. LivaNova PLC
14. DePuy Synthes Inc

Frequently Asked Questions

1. What is the projected market size & growth rate of the Neurostimulation Devices Market?
Ans- The Neurostimulation Devices Market was valued at USD 6.42 billion in 2023 and is projected to reach USD 14.46 billion by 2030, growing at a CAGR of 12.3% during the forecast period.

2. What is the key driving factors for the growth of the Neurostimulation Devices Market?
Ans- The market is expected to increase due to the availability of implanted neurostimulation devices that target particular cranial, spinal, and peripheral nerve regions.

3. Which Region accounted for the largest Neurostimulation Devices Market share?
Ans- North America had the greatest revenue share in 2023, and this dominance is expected to continue over the forecast period.

4. What makes Asia Pacific a Lucrative Market for Neurostimulation Devices Market?
Ans- market expansion in the APAC region is expected to be aided by rapid economic development in emerging countries such as India and China, as well as growing healthcare expenditures.

5. What are the top players operating in the Neurostimulation Devices Market?
Ans- Medtronic, Cyberonics, Boston Scientific Corporation, St. Jude Medical, and Nevro Corporation.

1. Neurostimulation Devices Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Neurostimulation Devices Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Key Players Benchmarking 2.4.1. Company Name 2.4.2. Business Segment 2.4.3. End-user Segment 2.4.4. Growth Rate (Y-O-Y %) 2.4.5. Revenue (2023) 2.4.6. Profit Margin 2.4.7. Market Share 2.4.8. Key Development 2.5. Market Size Estimation Methodology 2.5.1. Bottom-Up Approach 2.5.2. Top-Down Approach 2.6. Industry Ecosystem 2.6.1. Key Players in the Neurostimulation Devices Industry Ecosystem 2.6.2. Role and Impact of Companies in the Neurostimulation Devices Industry Ecosystem 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Mergers and Acquisitions Details 3. Neurostimulation Devices Market: Dynamics 3.1. Neurostimulation Devices Market Trends 3.2. Neurostimulation Devices Market Dynamics 3.2.1.1. Drivers 3.2.1.2. Restraints 3.2.1.3. Opportunities 3.2.1.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Customer Bargaining Power 3.3.2. Supplier Bargaining Power 3.3.3. Threat of New Entrants 3.3.4. Rivalry of Competitors 3.3.5. Threat of Substitute Products 3.4. PESTLE Analysis 3.5. Value Chain Analysis 3.5.1. Research and Development 3.5.2. Manufacturing and Assembly 3.5.3. Distribution 3.5.4. Marketing and sales 3.5.5. Post-Sales services 3.6. Supply Chain Analysis 3.7. Regulatory Landscape By Region 3.7.1. North America 3.7.2. Europe 3.7.3. Asia Pacific 3.7.4. South America 3.7.5. MEA 3.8. Key Opinion Leader Analysis for the Neurostimulation Devices Industry 3.9. Price Analysis 3.9.1. Average Selling Price Trend 3.10. Technology Analysis 3.11. Import and Export Trade Analysis By Region 4. Neurostimulation Devices Market: Global Market Size and Forecast By Segmentation (By Value in USD Bn) (2023-2030) 4.1. Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 4.1.1. Spinal Cord Stimulator 4.1.2. Deep Brain Stimulator 4.1.3. Sacral Nerve Stimulator 4.1.4. Vagus Nerve Stimulator 4.1.5. Gastric Electric Stimulator 4.2. Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 4.2.1. Pain Management 4.2.2. Epilepsy 4.2.3. Essential Tremor 4.2.4. Urinary and Fecal Incontinence 4.2.5. Depression 4.2.6. Dystonia 4.2.7. Others 5. North America Neurostimulation Devices Market Size and Forecast By Segmentation (By Value in USD Billion) (2023-2030) 5.1. North America Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 5.1.1. Spinal Cord Stimulator 5.1.2. Deep Brain Stimulator 5.1.3. Sacral Nerve Stimulator 5.1.4. Vagus Nerve Stimulator 5.1.5. Gastric Electric Stimulator 5.2. North America Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 5.2.1. Pain Management 5.2.2. Epilepsy 5.2.3. Essential Tremor 5.2.4. Urinary and Fecal Incontinence 5.2.5. Depression 5.2.6. Dystonia 5.2.7. Others 5.3. North America Neurostimulation Devices Market Size and Forecast, By Country (2023-2030) 5.3.1. United States 5.3.1.1. United States Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 5.3.1.1.1. Spinal Cord Stimulator 5.3.1.1.2. Deep Brain Stimulator 5.3.1.1.3. Sacral Nerve Stimulator 5.3.1.1.4. Vagus Nerve Stimulator 5.3.1.1.5. Gastric Electric Stimulator 5.3.1.2. United States Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 5.3.1.2.1. Pain Management 5.3.1.2.2. Epilepsy 5.3.1.2.3. Essential Tremor 5.3.1.2.4. Urinary and Fecal Incontinence 5.3.1.2.5. Depression 5.3.1.2.6. Dystonia 5.3.1.2.7. Others 5.3.2. Canada 5.3.2.1. Canada Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 5.3.2.1.1. Spinal Cord Stimulator 5.3.2.1.2. Deep Brain Stimulator 5.3.2.1.3. Sacral Nerve Stimulator 5.3.2.1.4. Vagus Nerve Stimulator 5.3.2.1.5. Gastric Electric Stimulator 5.3.2.2. Canada Neurostimulation Devices Market Size and Forecast, By Application (2023-2030) 5.3.2.2.1. Pain Management 5.3.2.2.2. Epilepsy 5.3.2.2.3. Essential Tremor 5.3.2.2.4. Urinary and Fecal Incontinence 5.3.2.2.5. Depression 5.3.2.2.6. Dystonia 5.3.2.2.7. Others 5.3.3. Mexico 5.3.3.1. Mexico Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 5.3.3.1.1. Spinal Cord Stimulator 5.3.3.1.2. Deep Brain Stimulator 5.3.3.1.3. Sacral Nerve Stimulator 5.3.3.1.4. Vagus Nerve Stimulator 5.3.3.1.5. Gastric Electric Stimulator 5.3.3.2. Mexico Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 5.3.3.2.1. Pain Management 5.3.3.2.2. Epilepsy 5.3.3.2.3. Essential Tremor 5.3.3.2.4. Urinary and Fecal Incontinence 5.3.3.2.5. Depression 5.3.3.2.6. Dystonia 5.3.3.2.7. Others 6. Europe Neurostimulation Devices Market Size and Forecast By Segmentation (By Value in USD Billion) (2023-2030) 6.1. Europe Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 6.2. Europe Neurostimulation Devices Market Size and Forecast, By Country (2023-2030) 6.2.1. United Kingdom 6.2.1.1. United Kingdom Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 6.2.1.2. United Kingdom Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 6.2.2. France 6.2.2.1. France Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 6.2.2.2. France Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 6.2.3. Germany 6.2.3.1. Germany Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 6.2.3.2. Germany Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 6.2.4. Italy 6.2.4.1. Italy Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 6.2.4.2. Italy Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 6.2.5. Spain 6.2.5.1. Spain Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 6.2.5.2. Spain Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 6.2.6. Sweden 6.2.6.1. Sweden Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 6.2.6.2. Sweden Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 6.2.7. Austria 6.2.7.1. Austria Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 6.2.7.2. Austria Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 6.2.8. Rest of Europe 6.2.8.1. Rest of Europe Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 6.2.8.2. Rest of Europe Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7. Asia Pacific Neurostimulation Devices Market Size and Forecast By Segmentation (By Value in USD Billion) (2023-2030) 7.1. Asia Pacific Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.2. Asia Pacific Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3. Asia Pacific Neurostimulation Devices Market Size and Forecast, By Country (2023-2030) 7.3.1. China 7.3.1.1. China Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.1.2. China Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3.2. S Korea 7.3.2.1. S Korea Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.2.2. S Korea Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3.3. Japan 7.3.3.1. Japan Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.3.2. Japan Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3.4. India 7.3.4.1. India Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.4.2. India Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3.5. Australia 7.3.5.1. Australia Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.5.2. Australia Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3.6. Indonesia 7.3.6.1. Indonesia Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.6.2. Indonesia Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3.7. Malaysia 7.3.7.1. Malaysia Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.7.2. Malaysia Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3.8. Vietnam 7.3.8.1. Vietnam Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.8.2. Vietnam Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3.9. Taiwan 7.3.9.1. Taiwan Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.9.2. Taiwan Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 7.3.10. Rest of Asia Pacific 7.3.10.1. Rest of Asia Pacific Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 7.3.10.2. Rest of Asia Pacific Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 8. South America Neurostimulation Devices Market Size and Forecast By Segmentation (By Value in USD Billion) (2023-2030) 8.1. South America Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 8.2. South America Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 8.3. South America Neurostimulation Devices Market Size and Forecast, By Country (2023-2030) 8.3.1. Brazil 8.3.1.1. Brazil Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 8.3.1.2. Brazil Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 8.3.2. Argentina 8.3.2.1. Argentina Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 8.3.2.2. Argentina Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 8.3.3. Rest Of South America 8.3.3.1. Rest of South America Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 8.3.3.2. Rest of South America Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 9. Middle East and Africa Neurostimulation Devices Market Size and Forecast By Segmentation (By Value USD Bn) (2023-2030) 9.1. Middle East and Africa Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 9.2. Middle East and Africa Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 9.3. Middle East and Africa Neurostimulation Devices Market Size and Forecast, By Country (2023-2030) 9.3.1. South Africa 9.3.1.1. South Africa Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 9.3.1.2. South Africa Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 9.3.2. GCC 9.3.2.1. GCC Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 9.3.2.2. GCC Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 9.3.3. Rest Of MEA 9.3.3.1. Rest Of MEA Neurostimulation Devices Market Size and Forecast, By Product(2023-2030) 9.3.3.2. Rest Of MEA Neurostimulation Devices Market Size and Forecast, By Application(2023-2030) 10. Company Profile: Key Players 10.1. Medtronic Plc 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview (Total Revenue, Segment Revenue, and Regional Revenue) 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Abbott Laboratories 10.3. Boston Scientific Corporation 10.4. LivaNova Plc 10.5. Nevro Corp 10.6. Nuvectra Corporation 10.7. NeuroPace Inc. 10.8. Synapse Biomedical Inc. 10.9. Stimwave Technologies 10.10. Aleva Neurotherapeutics SA 10.11. Cochlear Ltd. 10.12. ElectroCore, Inc. 10.13. Inspire Medical Systems, Inc. 10.14. Axonics Modulation Technologies, Inc. 10.15. NeuroSigma, Inc. 10.16. SPR Therapeutics 10.17. Mainstay Medical International Plc 10.18. Bioness Inc. 10.19. Functional Neuromodulation Ltd. 10.20. BioControl Medical 11. Key Findings 12. Analyst Recommendations 12.1. Attractive Opportunities for Players in the Neurostimulation Devices Market 12.2. Future Outlooks 13. Neurostimulation Devices Market: Research Methodology

Global Neuromodulation Market

Choose License Type